---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-076308"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T15:06:36.779431+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics elects three Class II directors and ratifies Ernst & Young at annual meeting

## Summary
- Elected Class II directors: Cynthia Butitta, Timothy Walbert, Alessandro Riva; each term until 2026.
- Butitta: 50.6M for, 0.8M withheld; Walbert: 47.6M for, 3.9M withheld; Riva: 50.7M for, 0.8M withheld.
- Broker non-votes on director election: 3,952,285.
- Ratified Ernst & Young as independent auditor for 2023: 55.4M for, 5K against, 2.8K abstentions.

## SEC filing metadata
- accession: 0001104659-23-076308
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/0001104659-23-076308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/tm2320170d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-076308
- JSON: https://secwatch.observer/filing/0001104659-23-076308.json
- Plain text: https://secwatch.observer/filing/0001104659-23-076308.txt

## Key facts
- Shareholder Votes
  Century Therapeutics, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2023-06-27 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-27
  source text: The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified, as follows: Votes For Votes Against Abstentions Broker Non-Votes 55,396,113 5,068 2,839 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/0001104659-23-076308-index.htm
- Shareholder Votes
  Century Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2023-06-27 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-27
  source text: Each of Cynthia Butitta, Timothy Walbert and Alessandro Riva, M.D. were elected to the Board to serve as Class II directors until the 2026 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Cynthia Butitta 50,643,653 808, 082 3,952,285 Timothy Walbert 47,566,726 3,885,009 3,952,285 Alessandro Riva, M.D. 50,658,311 793,424 3,952,285
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/0001104659-23-076308-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.